---
title: "\"Performance\" LUXXU GROUP's mid-term loss narrowed to 5.59 million RMB"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255340873.md"
description: "LUXXU GROUP announced its interim results for the six months ending in June, with revenue recorded at RMB 21.37 million, a year-on-year decrease of 3.3%. The loss narrowed from RMB 10.73 million in the same period last year to RMB 5.59 million, with a loss per share of 3.5 cents. No dividend is declared"
datetime: "2025-08-31T08:49:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255340873.md)
  - [en](https://longbridge.com/en/news/255340873.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255340873.md)
---

# "Performance" LUXXU GROUP's mid-term loss narrowed to 5.59 million RMB

LUXXU GROUP (01327.HK) announced its interim results for the six months ending in June, with revenue recorded at RMB 21.37 million, a year-on-year decrease of 3.3%. The loss narrowed from RMB 10.73 million in the same period last year to RMB 5.59 million, with a loss per share of 3.5 cents. No dividend was declared

### Related Stocks

- [01327.HK](https://longbridge.com/en/quote/01327.HK.md)

## Related News & Research

- [Luxxu Group Raises HK$20.8 Million Through Share Placing to Reduce Debt](https://longbridge.com/en/news/290821652.md)
- [Wall Street Hasn’t Discovered This Winning Stock. That Means Now Could Be a Good Time to Buy.](https://longbridge.com/en/news/290716701.md)
- [Valuation Reboot: Tracking the Tectonic Shifts Across 82 Key HK & US Equities](https://longbridge.com/en/news/290538509.md)
- [Fosun Pharma unit Fosun Adgenvax files for Hong Kong IPO in proposed spin-off listing](https://longbridge.com/en/news/290957351.md)
- [CITIC Resources says unaware of reasons behind unusual share moves, flags 10.01% stake sale by Chan Kin vehicle](https://longbridge.com/en/news/290978997.md)